The rVSV-ZEBOV vaccine against Ebola is 100% successful in trials involving 4000 people which are conducted in Guinea. Brende says:
Having seen the devastating effects of Ebola on communities and even whole countries with my own eyes, I am very encouraged by today’s news. This new vaccine, if the results hold up, may be the silver bullet against Ebola, helping to bring the current outbreak to zero and to control future outbreaks of this kind. I would like to thank all partners who have contributed to achieve this sensational result, due to an extraordinary and rapid collaborative effort.